Multiple Ascending Doses of Globalagliatin Hydrochloride in Type 2 Diabetes Mellitus

NCT03414892 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hyperglycaemia (Diabetic)
Type 2 Diabetes Mellitus

Interventions

DRUG: Globalagliatin Hydrochloride
DRUG: Placebo

Sponsor

Yabao Pharmaceutical Group